FEATURED NEWS

MATEC
May 11, 2017
FDA Updates STRIBILD and TYBOST labels May 4, 2017 The STRIBILD and TYBOST labels were updated to include revised text regarding corticosteroids as follows: STRIBILD Section 7 Drug Interaction, Table 6 was revised for systemic, inhaled, nasal, and opthalmic corticosteroids as follows. Table 6 Established and Other Potentially Significant Drug MORE
MATEC
April 7, 2017
Adult and Adolescent Opportunistic Infections Guidelines Updated U.S. Department of Health and Human Services, April 7, 2017: The Malaria section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents was recently updated. In this revision, the epidemiology and treatment sections were updated MORE
MATEC
March 24, 2017
Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents The Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV Infected Adults and Adolescents document was published in an electronic format that could be easily updated as relevant changes in prevention and MORE
MATEC
July 14, 2016
New CDC MMWR report on antibiotic-resistant gonorrhea includes concerning findings for azithromycin - one of two drugs in the only recommended treatment regimen Centers for Disease Control and Prevention (CDC), July 14, 2016. On July 14, 2016 CDC, On July 14, 2016, the Centers for Disease Control and Prevention (CDC) MMWR report titled Neisseria MORE
FDA
March 24, 2016
Update: Meningococcal Vaccine Recommendations March 18th, Chicago Department of Public Health. The Chicago Department of Public Health (CDPH) is investigating a new case of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup C reported in March 2016, 9 months following the last case tied to a Chicago-area outbreak of serogroup MORE
FDA
March 4, 2016
Updated HHS Pediatric Antiretroviral Treatment Guidelines Released >Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral, Department of Health and Human Services. Updated March 1, 2016 The HHS Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children announces MORE
FDA
February 1, 2016
U.S. Food and Drug Administration, January 28, 2016 The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Hepatitis C is a viral disease that causes inflammation of the liver that can lead to MORE
FDA
January 29, 2016
Updated Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents U.S. Department of Health and Human Services (HHS), January 28, 2016 The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents announces the release of the updated What's New in the Guidelines. Additions and revisions are also highlighted in yellow MORE
MATEC
December 1, 2015
December 1st is World AIDS Day. The 2015 theme is "The Time to Act is Now." Watch a live webcast of the White House World AIDS Day event on Tuesday, December 1 from 1:00 pm - 3:15 pm. Go to: https://www.whitehouse.gov/live. Pre-registration is not required. Visit this AIDS.gov page for more resources. Click here! Follow the conversation at #WAD2015.
MATEC
October 29, 2015
The Journal of the Association of Nurses in Aids Care recently published an article written by a team here at MATEC. From the abstract: Engaging new clinical providers in the HIV workforce is a critical need due to rapidly evolving treatment paradigms, aging out of existing providers, and special population needs. The 1-year competency-based Clinician MORE
MATEC
October 9, 2015
Wednesday, October 14, 2015 Nicollet Island Inn 95 Merriam St Minneapolis, MN 55401 Description: The QCR meeting is designed for physicians, physician assistants, nurse practitioners, and clinical pharmacists with a relatively high volume of HIV patients (this meeting is by invitation/nomination). Attendees are interested in case consultation with MORE
FDA
October 7, 2015
Dear Colleagues, The Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents has released updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. For a complete preview of key updates, please see What's New in the Guidelines via the AIDSinfo Clinical Guidelines portal MORE

Pages